HOME >> BIOLOGY >> NEWS
Tiny RNAs-'biological equivalent of dark matter'-wins prestigious AAAS Newcomb Cleveland Prize

The discovery of micro-sized RNA molecules (miRNAs)-a breakthrough described as "the biological equivalent of dark matter, all around us but almost escaping detection"-earned the coveted 2001-2002 AAAS Newcomb Cleveland Prize.

Three journal reports, published in the 26 October 2001 issue of Science, were named to receive the Prize, the oldest award conferred by the American Association for the Advancement of Science (AAAS). The AAAS Newcomb Cleveland Prize was established in 1923, with funds donated by Newcomb Cleveland of New York City, to recognize outstanding Science articles.

The award-winning research provides new insights into gene expression-the fundamental process by which information in life's blueprint, DNA, is transferred to messenger RNA (mRNA) and then translated into proteins. Understanding how protein production is controlled during gene expression is essential to unraveling the mysteries of all life processes, including, for example, the development of disease.

The AAAS Newcomb Cleveland Prize was awarded to three research teams at the Dartmouth Medical School in Hanover, New Hampshire; the Whitehead Institute for Biomedical Research and Massachusetts Institute of Technology in Cambridge, Massachusetts; and Germany's Max Planck Institute for Biophysical Chemistry.

Together, the winning articles "reveal the completely unexpected abundance of ultra-small RNA molecules, only 20 to 24 nucleotides long," explained Donald Kennedy Editor-in-Chief of Science. "What we've learned is that these abundant microRNAs are evolutionarily conserved across a number of organisms, and may affect gene regulation involved in the development of many types of cells and tissues. The outstanding contributions of these three research teams have thus written a new chapter in our understanding of gene control, and are arguably among the most significant biomedical research papers published in 2001."

In studies of the worm, C. elegans, for
'"/>


16-Jan-2003


Page: 1 2 3

Related biology news :

1. New lower-cost assay system equivalent to flow cytometry for accurate CD4+/CD8+ cell counts
2. The ecological equivalent of Ellis Island: from ancestry to biodiversity
3. Gladstone investigator Mike McCune wins prestigious NIH Directors Pioneer Award
4. Carnegie Mellon computational biologist Russell Schwartz receives prestigious CAREER award
5. Brown earns prestigious geography award
6. Ohio State wetlands professor wins prestigious Water Prize
7. Top US scientist honored with prestigious award
8. Dr. Walter Reich, Ph.D., receives prestigious AAAS 2003 Scientific Freedom and Responsibility Award
9. John Allen Paulos receives prestigious AAAS Award for Public Understanding of S&T
10. UT Southwestern scientist awarded prestigious American Cancer Society research professorship
11. Field Museum gives prestigious Parker Gentry Award to Tanzanian anti-poaching activist

Post Your Comments:
(Date:8/12/2015)... , Aug. 12, 2015   MedNet Solutions ... the entire spectrum of clinical research, is proud to ... the company,s comprehensive SaaS-based eClinical technology platform, has led ... the first two quarters of 2015.   Q2 2015 ... largest quarters measured by contract value sold in the ...
(Date:8/12/2015)... Aug. 12, 2015  New research unveiled at ... Android phones to steal users, fingerprints. Information released ... of fingerprint scanners on mobile devices, making the ... secure biometrics on mobile devices, HYPR Corp. recently ... convenient authentication systems with strong cryptographic security. More ...
(Date:8/11/2015)... -- Today, ZUK announced its Android smartphone Z1, featuring ... revenues in 2015 that relate to sales of FPC1155 for this ... 2,200 MSEK for 2015. Jörgen Lantto, CEO of FPC, ... smartphone manufacturer in China and we ... 155 for Z1 , ...
Breaking Biology News(10 mins):MedNet Solutions Experiences Explosive Corporate Growth 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 3FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2
(Date:8/27/2015)... GlassesOff (OTCBB: GLSO), a visual neuroscience technology company ... system, announced today a partnership with eight-time All-Star, ... to develop a new mobile app designed for professional and ... performance. Vision is the inception of every move ... or blocking a pass. The critical impact vision speed has ...
(Date:8/26/2015)... ... August 26, 2015 , ... MediVet Biologics, a leader in ... is to open in Manhattan, Kansas in early October, 2015. The location of ... research and development through collaboration with researchers from Kansas State University’s College of ...
(Date:8/26/2015)... , Aug. 26, 2015  Platform therapeutic company ... has received a $1.5M Phase II SBIR grant ... further develop its therapeutic agent to reduce arteriovenous ... in end stage renal disease (ESRD) patients undergoing ... Institute of Diabetes and Digestive and Kidney Diseases ...
(Date:8/26/2015)... 26, 2015 Despite recent ... the optimism in biotech,s forecast is the recent ... sciences advancements.  Active biotechnology & healthcare companies with ... (OTCQB: PBIO), Sequenom, Inc. (NASDAQ: SQNM ), ... Pharmaceutical Corp. (NASDAQ: RPTP ) and EnteroMedics ...
Breaking Biology Technology:Eight-Time All-Star Chris Paul and GlassesOff Partner to Develop Innovative Mobile App Designed to Improve On-Court Performance 2Eight-Time All-Star Chris Paul and GlassesOff Partner to Develop Innovative Mobile App Designed to Improve On-Court Performance 3MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas 2MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas 3Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 2New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 3New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 4New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 5New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 6New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 7
Cached News: